NEWS
Hospitals Cut C. Diff While Candida Auris Surged Tenfold
CDC’s 2026 report counts 50,800 U.S. deaths from drug-resistant germs, yet C. diff left the urgent list after hospitals cut cases.
Drug-resistant germs caused 9.7 million U.S. infections and 50,800 deaths in 2023, the Centers for Disease Control and Prevention said in a report released October 27, 2026. Four of 19 bacteria and fungi on the list are tagged urgent, led by a hospital fungus that has climbed nearly tenfold.
The same report pulled Clostridioides difficile off that urgent list after hospitals cut cases with infection control and tighter antibiotic use. CDC Director Erica Schwartz, MD, MPH, JD, said antimicrobial resistance “threatens modern medicine and puts millions of Americans at risk every year,” and that the figures show “both the progress we’ve made and the significant work that remains.”
C. Diff Left the Urgent List After Hospitals Cut Cases
C. diff causes diarrhea and colitis, and it is often kicked off by antibiotics that wipe out helpful gut bacteria. It is not typically a drug-resistant germ. CDC still puts it in the threats report because the same two habits that breed resistance, extra antibiotic use and germs moving from person to person, also drive C. diff.
In 2023 it caused 412,504 infections among hospitalized and non-hospitalized patients, 11,339 deaths among hospital patients, and $6.4 billion in healthcare costs. Adults 65 and older get it at 4.5 to 5 times the rate of younger people, even after a 28% drop in the older-adult rate from 2018 to 2020.
THE C. DIFF RECORD
- 2011 onward: CDC measures falling case counts in healthcare settings and keeps C. diff on the urgent list in the 2013 and 2019 reports.
- 2018 to 2020: Total cases declined by an unadjusted 21% in both healthcare-associated and community-associated disease, which CDC ties to better infection control and improved antibiotic use, with a possible assist from changes in testing.
- 2020 to 2023: Healthcare-associated cases stay relatively stable. Community-associated cases rise slightly as outpatient visits rebound after COVID-19.
- October 27, 2026: CDC recategorizes C. diff as a serious threat, citing those declines, proven prevention steps, and effective treatment.
The demotion is not a clean bill of health. C. diff remains one of the most common infections picked up in hospitals, and community-associated cases now outnumber the hospital ones in CDC’s wider count. November is also C. diff Awareness Month, which lands while the bacterium is still tied to more than 11,000 hospital deaths a year.
Christian John Lillis, co-founder of the Peggy Lillis Foundation, has spent years making that cost concrete. His mother, Peggy, was a healthy 56-year-old kindergarten teacher. After a root canal, her dentist prescribed clindamycin. Four days later she had diarrhea. By the time the family reached a hospital, she had toxic megacolon from C. diff and was in septic shock. She died about a week after the dental visit.
Antibiotics are miracle drugs. They underpin most modern medicine. To avoid unnecessary infections and prolong these drugs’ effectiveness, we must first see both the potential harms, as well as benefits, of antibiotics.
Christian John Lillis, co-founder, Peggy Lillis Foundation, on CDC’s C. diff page
Haley Ann Pritchard, MD, medical director of infection prevention and antimicrobial stewardship at Eskenazi Health Hospital in Indianapolis, said the decline shows hospitals are getting some return from the work they have already put in. “I would obviously like to see those numbers go down more, but it is at least nice that they’ve gone down some,” she said.
Candida Auris Rose Nearly Tenfold in the Same Buildings
Candida auris is a fungus that can cause mild skin infections or bloodstream infections that kill. CDC first counted a U.S. clinical case in 2016. In 2023, the threats report logged 4,523 clinical cases, a rise of more than 50% from 2022 and a nearly tenfold climb since 2019. CDC’s separate tracking page later counted 6,304 new clinical cases in 2024. The yearly percentage jumps have slowed since 2022. The absolute count has not.
C. AURIS IN THE U.S.
- 2023 clinical cases: 4,523, a national case count rather than a modeled estimate.
- 2024 clinical cases: 6,304 new cases reported to CDC.
- Drug failure: 96% of 2023 samples resisted fluconazole, 16% resisted amphotericin B, and 1% resisted echinocandins, the usual first-line drugs.
- Death range: Tom Chiller, MD, former chief of CDC’s Mycotic Diseases Branch, said resistant infections are fatal in 29% to 62% of patients.
The fungus lives on skin, lasts on surfaces, and moves through hospitals and nursing homes on breathing tubes, catheters, and the hands of staff. People can carry it without getting sick. A 2025 Nature study of a ventilator-capable nursing home found that skin is a reservoir for colonization by C. auris and by ESKAPE bacteria that already worry hospitals.
Chiller, now chief medical officer at the fungal diagnostics firm IMMY, said the country is short on antifungal drugs and still does not know how to clear the fungus from patients or rooms. “For C. auris we also need to figure out how to decolonize patients and rapidly disinfect healthcare environments. This will require lots more screening of patients and healthcare settings,” he said.
Johanna P. Daily, MD, a professor of medicine (infectious disease) and of microbiology and immunology at Montefiore-Einstein, put the hospital problem in one line: people go in to get better, and some leave with a more resistant germ than they brought.
Four Germs Now Sit on CDC’s Urgent List
CDC sorts 19 germs by threat: 4 urgent, 13 serious, and 2 concerning, plus a watch list of 6 whose U.S. burden is still unclear. Urgent means the agency wants aggressive action now. Beside C. auris sit three bacteria that shrug off carbapenems, among the broadest antibiotics left, or that have burned through sexually transmitted infection drugs.
URGENT THREATS, 2023 COUNTS
| Germ | Infections | Deaths | What CDC flagged |
|---|---|---|---|
| Candida auris | 4,523 | Not listed | Nearly tenfold rise; 96% fluconazole-resistant |
| Carbapenem-resistant Acinetobacter | 9,497 | 817 | Resists last-resort carbapenems |
| Carbapenem-resistant Enterobacterales (CRE) | 14,878 | 1,252 | 67% community-onset; shares resistance genes |
| Drug-resistant Neisseria gonorrhoeae | 787,000 | Not listed | Few drugs still work; nearly $215 million in lifetime medical costs |
CRE is a family of gut bacteria that includes E. coli. CDC researchers found CRE incidence at U.S. hospitals rose 18% from 2019 to 2023. Of the 14,878 CRE cases in 2023, 67% were community-onset, though some of those patients may have had recent healthcare contact. Pritchard said her hospital is seeing more CRE than it did five years ago, and she has already watched resistance appear to drugs that only came out in the past few years. “We really need more drugs,” she said.
Infections that commonly occur in hospital patients accounted for more than 42,000 of the deaths and more than $12 billion in healthcare costs. Wendy Armstrong, MD, president of the Infectious Diseases Society of America, said the totals are “alarming by any measure” and “particularly sobering when infectious diseases physicians connect real patients with these statistics in their everyday experience.”
CDC warns that the 9.7 million and 50,800 figures should not be lined up against the 2019 report’s 2.8 million infections and 35,000 deaths. Methods and data sources changed for every germ except C. auris. The 2026 update is the agency’s most complete U.S. count to date, not a simple before-and-after.
Most of the 9.7 Million Infections Start Outside Hospitals
Deaths cluster in hospitals and nursing homes. Case counts do not. Drug-resistant group A strep, now counted with noninvasive infections such as strep throat, caused about 2.0 million infections and 1,013 deaths. Drug-resistant Campylobacter, a leading foodborne germ, caused about 1.8 million infections. Drug-resistant gonorrhea caused 787,000 infections, a figure that has stayed above 740,000 since 2018.
In 2023, 55.4% of gonorrhea isolates showed resistance or a higher-than-normal MIC to at least one antibiotic CDC monitors, up from 47.8% in 2022. The jump was driven by older drugs no longer recommended for treatment, including tetracycline, penicillin, and ciprofloxacin. Untreated infection can lead to pelvic inflammatory disease, ectopic pregnancy, infertility, and a higher risk of HIV.
Drug-resistant Neisseria meningitidis is new to the serious list. It is uncommon in raw counts, 61 penicillin-resistant cases and 35 ciprofloxacin-resistant cases in 2023, but CDC said penicillin-resistant cases tripled and ciprofloxacin-resistant cases more than doubled from 2019 to 2023. Unlike C. auris, meningococcus spreads in ordinary close contact, including kissing, shared drinks, and crowded housing such as college dorms. In some parts of the country, resistant strains already account for more than half of reported meningococcal disease, which is why ciprofloxacin is no longer a safe default for preventing infection in close contacts in those areas.
Daily noted that some bacteria are now resisting carbapenems, the class clinicians reach for when other antibiotics fail. The urgent list is no longer a story that stops at the ICU door.
Steroid Creams Are Feeding Resistant Ringworm
CDC added drug-resistant dermatophytes, the fungi behind ringworm and athlete’s foot, to the 2026 watch list because the U.S. burden is still poorly measured. Cases are being reported here and abroad. Chiller said resistant strains can account for more than half of clinic visits in parts of India, and he is watching new species outrun the drugs on the shelf.
Three emerging types have already shown up in the United States: Trichophyton indotineae, terbinafine-resistant T. rubrum, and T. mentagrophytes genotype VII (TMVII). The first two often fail standard antifungals. TMVII is usually still treatable, but it spreads through sexual contact and can take weeks or months to clear. CDC tells clinicians to avoid topical corticosteroids, including combination steroid-antifungal creams, because they can make the rash look better while the fungus spreads, a pattern sometimes called tinea incognito.
That is a gym-bag and drugstore problem, not a ventilator problem. People share towels, razors, and mats. They buy a cream that calms redness and keep using it. Travel to South Asia raises the chance of meeting a resistant strain, and CDC asks patients with a stubborn rash to mention recent trips to India, Bangladesh, or nearby countries.
The rest of the watch list is equally close to ordinary life: azole-resistant Aspergillus fumigatus, drug-resistant whooping cough, drug-resistant Haemophilus influenzae, drug-resistant Mycoplasma genitalium, and nontuberculous mycobacteria. Two U.S. whooping cough cases with macrolide resistance turned up in 2024 and 2025, the first since 2018. If that resistance spreads, young children lose the usual first drug.
What You Can Do Before You Need an Antibiotic
CDC’s prevention page is blunt, and it matches the C. diff chapter. Antibiotics do not treat viruses, including colds and flu. Using them anyway raises the odds of C. diff and of breeding germs that survive the next prescription. The leftover-pill habit and the “just in case” prescription are the same mechanism Lillis described after a routine dental visit.
The argument over who is at fault, patients who ask or clinicians who write the script for a virus, misses the cheaper fact. Unused antibiotics still get swallowed, and the report already priced that pattern in hospital diarrhea, extra bed days, and 11,339 C. diff deaths.
CDC’S EVERYDAY LIST
- Hands: CDC says keeping your hands clean is one of the best ways to remove germs, with soap and water for at least 20 seconds or a sanitizer that is at least 60% alcohol.
- Vaccines: Shots prevent infections that would otherwise lead to antibiotics, including flu and meningococcal disease for adolescents and first-year students in residence halls.
- Drugs: Take antibiotics and antifungals only when a clinician prescribes them, and finish the course. Do not use leftover pills or steroid creams on an undiagnosed rash.
- Questions: Ask what the drug is for, whether a virus is more likely, and what infection risk comes with a hospital stay or a medical device.
Daily tells patients to speak up when they or a family member is sick. Pritchard’s warning is larger than infectious disease clinics. “Every joint replacement, every appendectomy, every surgery relies on having effective antibiotics to be successful,” she said. “You really cannot have all the benefits of modern medicine, even outside the realm of infectious diseases, without effective antibiotics. It all goes away.”
The 2023 counts in the October 27 report are already a year behind the fungus. CDC’s tracking page put 6,304 new C. auris clinical cases in 2024, while C. diff remains a serious threat at 412,504 infections. One of those curves bent because hospitals changed how they use drugs and clean rooms. The other has not.
Frequently Asked Questions
What Is Candida Auris?
Candida auris is a yeast that can colonize skin without causing symptoms or invade blood, urine, wounds, and other sites. CDC reports clinical cases when a sample is taken to diagnose suspected infection, and screening cases when a skin swab is taken only to see whether someone is carrying the fungus. People without the usual risk factors, long hospital stays, ventilators, catheters, or serious underlying illness, generally do not get infected or colonized.
Why Did CDC Move C. Diff Off the Urgent List?
CDC lowered C. diff from urgent to serious because case counts have fallen since 2011, especially in healthcare, and because hospitals already have proven tools: infection control, antibiotic stewardship, better testing, and working treatments. The germ is still in the report because antibiotic use and person-to-person spread drive it, not because it has become a classic superbug that shrugs off every drug.
Do Antibiotics Help a Cold or the Flu?
No. Antibiotics treat some bacterial illnesses, including strep throat, whooping cough, and many urinary tract infections, and even some of those get better without drugs. Colds, flu, most sore throats, and many cases of bronchitis are viral. Taking an antibiotic then still causes side effects and can set up C. diff or a later infection that the same drug cannot touch.
Why Are Steroid Creams a Problem for Ringworm?
Steroid creams, including over-the-counter steroid-antifungal combinations, weaken the skin’s local immune response. Redness fades, so the rash looks better, while the fungus spreads and the appearance changes enough that a later clinician may miss it. For suspected TMVII, CDC prefers oral terbinafine rather than a topical steroid mix, and it asks patients with severe or stubborn ringworm to mention travel to South Asia.
Which Vaccines Help Against Drug-Resistant Infections?
Vaccines cut the infections that lead to antibiotic prescriptions, which is why CDC lists shots beside handwashing on its prevention page. Meningococcal vaccines are recommended for adolescents and for first-year college students living in residence halls. Flu vaccine lowers the chance of a respiratory illness that still draws a pointless antibiotic. Whooping cough vaccine matters more if macrolide-resistant Bordetella pertussis, now on the watch list after two U.S. cases in 2024 and 2025, becomes common in young children.
Disclaimer: This article is news reporting and analysis of the CDC Antimicrobial Resistance Threats Report and related public-health guidance. It is for information only and is not medical advice, a diagnosis, or a treatment plan for any infection, rash, or antibiotic decision. Readers should talk with a licensed physician, pharmacist, or other qualified clinician before starting, stopping, or skipping an antibiotic, antifungal, vaccine, or cream, and before treating a suspected infection at home. Case counts, death estimates, and threat labels reflect the CDC sources cited for 2023 data and the October 27, 2026 report, and those figures can change as surveillance is updated.
-
NEWS3 months agoPennsylvania Measles Deaths Collide With Falling MMR Coverage
-
NEWS3 months agoFDA Approves XFG COVID Vaccines While the Advice Panel Is Frozen
-
NEWS3 months agoProgranulin and JAK2 Split the Macrophages That Heal
-
FITNESS3 months agoMuscle-Boosting Drugs Near Approval for Children With SMA
-
NEWS3 months agoAlnylam Defends Amvuttra After Wainua’s ATTR-CM Trial Miss
-
MENTAL HEALTH3 months agoAfter the ADHD Invoice, GPs and Waiters Carry the Cost
-
NEWS2 months agoRasonque’s List Price Shifts the Pancreatic Cancer Bill
-
NEWS3 months agoFDA Flagged This Sprout Plant 16 Months Before the Outbreak
